Check out the companies making headlines before the bell:

Pfizer – The drugmaker is buying Array Biopharma for $48 per share in cash, or $11.4 billion, including debt. That’s a 62% premium over Array’s Friday close. Array specializes in treatments for diseases where there is a large unmet need, as well as cancer drugs.

Boeing – Boeing CEO Dennis Muilenburg told reporters at the Paris Air Show that it will take time to win back the confidence of its customers following the two fatal

Read More At Article Source | Article Attribution